Prevalence, Risk Factors and Vaccine Response against Hepatitis B in People Aged 50 Years or Older.

Vaccines（2023）

引用 0|浏览5

暂无评分

摘要

reinforced doses should be used in individuals aged 50 years or older to overcome the lower efficacy of the vaccine against hepatitis B.

查看译文

关键词

elderly,epidemiology,hepatitis B vaccines,immunogenicity vaccine,middle aged

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要